Novartis on 4 Ways It Is Pursuing the Challenge of Treating Lung Cancer

Originally published on LinkedIn. Novartis Pharmaceuticals is a Fair360, formerly DiversityInc Hall of Fame company.

 

Lung cancer is the number one cause of death from cancer worldwide. Novartis Pharmaceuticals is currently pursuing the challenge on four fronts.

To learn more about Novartis’ advancements in helping to treat lung cancer, click here.